IL18 and metabolic dysfunction-associated steatohepatitis: In fact, increased proportion of Prevotellaceae and TM7 phylum in the microbiota from IL-18-/- mice led to an exacerbated influx of TLR4 and TLR9 agonists into the portal circulation, leading to hepatic overexpression of TNF-α that drives NASH progression (126).